Gelteq Limited Ordinary Shares
Gelteq Limited Ordinary Shares (GELS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GELS · as of Jun 8, 2026
Key Statistics
Explore Gelteq Limited Ordinary Shares Data
gels stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gels competitorsGELS
AYTU
BFRG
BFRI
BGLC
COCPStock Performance
Full HistoryAbout Gelteq Limited Ordinary Shares
Gelteq Limited Ordinary Shares Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers…
what is gelteq limited ordinary shares · gels stock overview · gelteq limited ordinary shares company profile · who is gelteq limited ordinary shares ceo · gels NASDAQ · gelteq limited ordinary shares headquarters · gelteq limited ordinary shares business segments
About Stock Overview & Key Data
Gelteq Limited Ordinary Shares (GELS) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Oct 29, 2024. As of the latest trading session, GELS stock price is $0.48, with a market capitalization of $4.4M. The stock has returned -71.76% over the past 12 months and -39.99% year-to-date.
In fiscal year 2025, Gelteq Limited Ordinary Shares reported revenue of $165645.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gelteq Limited Ordinary Shares (GELS) stock price is $0.48. The stock is traded on NASDAQ under the ticker symbol GELS. The 52-week range is $0.39 – $3.51.